Indian Journal of Palliative Care
Open access journal 
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size Users online: 400  
     Home | About | Feedback | Login 
  Current Issue Back Issues Editorial Board Authors and Reviewers How to Subscribe Advertise with us Contact Us Analgesic Prescription  
  Navigate Here 
 Search
 
  
 Resource Links
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (294 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this Article
   References

 Article Access Statistics
    Viewed1700    
    Printed74    
    Emailed0    
    PDF Downloaded82    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

 


 
Table of Contents 
LETTER TO EDITOR
Year : 2011  |  Volume : 17  |  Issue : 3  |  Page : 260

Anticoagulants and anti-platelet agents in palliative home healthcare


Wiwanitkit House, Bangkhae, Bangkok 10160, Thailand

Date of Web Publication28-Jan-2012

Correspondence Address:
Viroj Wiwanitkit
Wiwanitkit House, Bangkhae, Bangkok 10160,
Thailand
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0973-1075.92355

Rights and Permissions



How to cite this article:
Wiwanitkit V. Anticoagulants and anti-platelet agents in palliative home healthcare. Indian J Palliat Care 2011;17:260

How to cite this URL:
Wiwanitkit V. Anticoagulants and anti-platelet agents in palliative home healthcare. Indian J Palliat Care [serial online] 2011 [cited 2020 Sep 20];17:260. Available from: http://www.jpalliativecare.com/text.asp?2011/17/3/260/92355


Sir,

The recent report on anticoagulant (AC) and antiplatelet (AP) agents in the management of hematological malignancies in a home-care program was interesting. [1]

Tendas et al. concluded that 'AC/AP drugs have been very rarely responsible for significant complications.' [1] The question is whether the present use of AC/AP is clinically favorable. It is not surprising that the use of AC/AP in home healthcare was seen in only 20% of cases in their study. There could be many reasons for this observation. Based on the present report, there appears to be a high incidence of complications or adverse events of AC/AP drugs in clinical practice and, therefore, the use of these drugs in home healthcare for cases with hematological malignancies might be considered a risk. This is no doubt the reason why the use of AC/AP in home healthcare seems to be uncommon in this report. Nevertheless, it cannot be denied that AC/AP drugs are useful in the palliative care management of cases with hematological malignancies. The solution might be the implementation of point-of-care testing (POCT) to closely monitor the effect of AC/AP drugs. There are many easy to use POCT analyzers that can be used at patients' homes. [2] Using these tools can be helpful in monitoring of pharmacological effect of AC/AP drugs and in early detection of complications. The goal is to use AC/AP drugs for the patient, but without any complications.

 
  References Top

1.Tendas A, Cupelli L, Scaramucci L, Palombi M, Trawinska MM, Giovannini M, et al. Anticoagulant and anti-thrombotic treatments in the management of hematological malignancies in a home care program. Indian J Palliat Care 2011;17:54-6.  Back to cited text no. 1
[PUBMED]  Medknow Journal  
2.Levy JH, Dutton RP, Hemphill JC 3rd, Shander A, Cooper D, Paidas MJ, et al. Multidisciplinary approach to the challenge of hemostasis. Anesth Analg 2010;110:354-64.  Back to cited text no. 2
[PUBMED]  [FULLTEXT]  



This article has been cited by
1 Authors′ reply
# # Tendas, A., Cupelli, L., Scaramucci, L., Palombi, M., Trawinska, M.M., Giovannini, M., Brunetti, G.A., (...), Niscola, P.
Indian Journal of Palliative Care. 2011; 17(3): 260-261
[Pubmed]



 

Top
Print this article  Email this article
Online since 1st October '05
Published by Wolters Kluwer - Medknow